Though no previous reports of serum CK19-2G2 in breast cancer, another CK19 fragment, CYFRA21-1, have been investigated and found that elevated serum CYFRA21-1 levels were correlated with advanced stage, large size and positive lymph nodes but no correlation with ER and PR status. The gene discussed is ESR1; the disease is breast carcinoma.